CD79A and stroke disorder: Multiple studies revealed that there were no significant differences in serum IgG (Hosomi et al. 2012; Leskelä et al. 2020; Palm et al. 2014; Pussinen et al. 2004) or IgA titers (Leskelä et al. 2020; Palm et al. 2014; Pussinen et al. 2004), as well as seropositivity (Palm et al. 2014, 2016; Pussinen et al. 2007), among patients with or without stroke.